GNMSF News and Press, Genmab A/S Dkk From 02/21/18

Genmab ( OTCPK:GNMSF ): FY Operating income of DKK1.34B. More news on: Genmab A/S, Genmab A/S ADR, Earnings news and commentary, Tech stocks news, Read more ...

Company Announcement  Copenhagen, Denmark; February 21, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2017.  Below is a summary of business progress and financial performance for the year, and financial outlook for ...

Note: Subscribers to Avisol Capital Partners' Total Pharma Tracker got an early look at this publication. Consider becoming a subscriber today to get early access! Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep p...

Company Announcement  Net sales of DARZALEX in 2017 totaled USD 1,242 million Genmab receives royalties on worldwide sales from Janssen Biotech, Inc.   Copenhagen, Denmark; January 23, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) an...

Citing low the low number of chronic lymphocytic leukemia (CLL) being treated with Arzerra (ofatumumab) outside of the U.S., Novartis (NYSE: NVS ) will transition the product from commercial availability to limited availability via compassionate use programs in all ex-U.S. markets. More ...

Company Announcement  Novartis intends to transition the commercial availability of Arzerra to limited availability via compassionate use programs for treatment of CLL in non-US markets. Novartis will continue to market for CLL in the US Novartis will work with r...

Company Announcement U.S. FDA grants Priority Review to daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant May 21, 2018 PDUFA date ...

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; January 9, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danish Securities Trading Act that Artisan Partners Limited Partn...